• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过评估血清和泪液中 VEGF 和 sVEGFR2 的浓度,探讨血管生成因子在硬皮病血管变化形成中的作用。

The Role of Angiogenesis Factors in the Formation of Vascular Changes in Scleroderma by Assessment of the Concentrations of VEGF and sVEGFR2 in Blood Serum and Tear Fluid.

机构信息

Department of Ophthalmology and Vision Rehabilitation, Medical University of Lodz, Zeromskiego 113, 90-549 Lodz, Poland.

Department of Dermatology and Venerology, Medical University of Lodz, Hallera 1, 90-647 Lodz, Poland.

出版信息

Mediators Inflamm. 2020 Jan 24;2020:7649480. doi: 10.1155/2020/7649480. eCollection 2020.

DOI:10.1155/2020/7649480
PMID:32410862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7204106/
Abstract

Systemic sclerosis (SSc) is a connective tissue disorder characterized by tissue hypoxia, excessive fibrosis of skin and internal organs, and angiogenesis imbalance. The aim of the study was to evaluate in SSc patients the association between the retinal microcirculation disturbances and the presence of peripheral trophic changes and to determine the role of angiogenesis factors in the formation of vascular changes in scleroderma. Twenty-five SSc patients and 25 age- and sex-matched healthy controls were included to the study. Assay of vascular endothelial growth factor (VEGF) and soluble VEGF receptor-2 (sVEGFR-2) in blood serum and tears was done for all patients and controls using enzyme-linked immunosorbent assay. Retinal blood circulation was investigated with fluorescein angiography (FA) in the SSc patients only. In our research, proportion of mainly hypertensive patients presenting with a large spectrum of retinal microvascular lesions was 72%, while proportion of patients with skin microvascular lesions within distal phalanxes of fingers and toes was 76%. We noticed that patients with pathological changes in the FA examination had finger ulcerations significantly more often than patients without changes in the eye fundus. There were no statistically significant differences in the serum concentration of VEGF and sVEGFR2 between subjects in both analyzed groups. Analysis of lower levels of VEGF ( = <0.001) and sVEGFR-2 ( = <0.001) in blood serum accompanied by simultaneous higher levels of VEGF/sVEGFR-2 ratio in tears of SSc patients, as compared with the control group, indicates the superiority of proangiogenic factors in patients' tears.

摘要

系统性硬化症(SSc)是一种结缔组织疾病,其特征为组织缺氧、皮肤和内脏器官过度纤维化以及血管生成失衡。本研究旨在评估 SSc 患者视网膜微循环障碍与外周营养障碍的相关性,并确定血管生成因子在硬皮病血管变化形成中的作用。本研究纳入了 25 例 SSc 患者和 25 名年龄和性别匹配的健康对照者。采用酶联免疫吸附试验检测所有患者和对照者血清和泪液中的血管内皮生长因子(VEGF)和可溶性 VEGF 受体-2(sVEGFR-2)。仅对 SSc 患者进行荧光素血管造影(FA)检查视网膜血液循环。在我们的研究中,主要表现为高血压且具有广泛视网膜微血管病变的患者比例为 72%,而手指和脚趾远端指节皮肤微血管病变的患者比例为 76%。我们注意到 FA 检查有病变的患者手指溃疡明显多于眼底无变化的患者。在这两个分析组中,血清 VEGF 和 sVEGFR2 浓度在受试者之间没有统计学差异。与对照组相比,SSc 患者血清中 VEGF( = <0.001)和 sVEGFR-2( = <0.001)水平较低,同时泪液中 VEGF/sVEGFR-2 比值较高( = <0.001),表明患者泪液中促血管生成因子具有优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911e/7204106/7cd8f7ffe3b9/MI2020-7649480.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911e/7204106/48a9e9daa998/MI2020-7649480.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911e/7204106/de9da7292a54/MI2020-7649480.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911e/7204106/2f01cf25894b/MI2020-7649480.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911e/7204106/7cd8f7ffe3b9/MI2020-7649480.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911e/7204106/48a9e9daa998/MI2020-7649480.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911e/7204106/de9da7292a54/MI2020-7649480.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911e/7204106/2f01cf25894b/MI2020-7649480.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911e/7204106/7cd8f7ffe3b9/MI2020-7649480.004.jpg

相似文献

1
The Role of Angiogenesis Factors in the Formation of Vascular Changes in Scleroderma by Assessment of the Concentrations of VEGF and sVEGFR2 in Blood Serum and Tear Fluid.通过评估血清和泪液中 VEGF 和 sVEGFR2 的浓度,探讨血管生成因子在硬皮病血管变化形成中的作用。
Mediators Inflamm. 2020 Jan 24;2020:7649480. doi: 10.1155/2020/7649480. eCollection 2020.
2
[Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].[系统性硬化症和局限性硬皮病——参与皮肤中负责血管变化和CD34表达的特定血清参数紊乱]
Przegl Lek. 2009;66(12):1040-5.
3
Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1.硝苯地平可降低系统性硬化症患者血清血管细胞黏附分子-1(sVCAM-1)浓度及氧化应激水平,但不影响血管内皮生长因子及其可溶性受体1的浓度。
Arthritis Res Ther. 2004;6(4):R309-14. doi: 10.1186/ar1183. Epub 2004 May 12.
4
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.系统性硬化症中的血管生成和血管抑制因子:血管内皮生长因子水平升高是疾病最早阶段的一个特征,且与无指尖溃疡相关。
Arthritis Res. 2002;4(6):R11. doi: 10.1186/ar596. Epub 2002 Aug 30.
5
Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis-Case Series Report.基质金属蛋白酶 MMP-2 和 MMP-9、它们的抑制剂 TIMP-1 和 TIMP-2、血管内皮生长因子和 sVEGFR-2 作为系统性硬化症患者缺血性视网膜病变的预测标志物:病例系列报告。
Int J Mol Sci. 2020 Nov 18;21(22):8703. doi: 10.3390/ijms21228703.
6
Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity.系统性硬化症患者血清 Ang1、Ang2 和 VEGF 水平失衡:对微血管反应性的综合影响。
Microvasc Res. 2019 Sep;125:103881. doi: 10.1016/j.mvr.2019.103881. Epub 2019 May 7.
7
Pro- and antiangiogenic markers in patients with pulmonary complications of systemic scleroderma.系统性硬化症肺部并发症患者的促血管生成和抗血管生成标志物
Respir Physiol Neurobiol. 2015 Apr;209:69-75. doi: 10.1016/j.resp.2014.10.018. Epub 2014 Nov 5.
8
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.丛状蛋白-D1/信号素3E通路可能导致系统性硬化症中血管张力控制失调和血管生成缺陷。
Arthritis Res Ther. 2015 Aug 21;17(1):221. doi: 10.1186/s13075-015-0749-4.
9
Dysregulation of angiogenic homeostasis in systemic sclerosis.系统性硬化症中血管生成稳态的失调。
Int J Rheum Dis. 2013 Aug;16(4):448-54. doi: 10.1111/1756-185X.12130. Epub 2013 Jul 2.
10
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.血管内皮生长因子(VEGF)165b 的过表达是一种血管内皮生长因子的抑制性剪接变异体,可导致系统性硬化症患者的血管生成不足。
Circ Res. 2011 Jul 22;109(3):e14-26. doi: 10.1161/CIRCRESAHA.111.242057. Epub 2011 Jun 2.

引用本文的文献

1
Vascular endothelial growth factor as a potential biomarker in systemic sclerosis: a systematic review and meta-analysis.血管内皮生长因子作为系统性硬化症的潜在生物标志物:一项系统评价和荟萃分析。
Front Immunol. 2024 Nov 28;15:1442913. doi: 10.3389/fimmu.2024.1442913. eCollection 2024.
2
VEGFA may be a potential marker of myopic choroidal thickness and vascular density changes.VEGFA 可能是近视脉络膜厚度和血管密度变化的潜在标志物。
Sci Rep. 2024 Sep 3;14(1):20514. doi: 10.1038/s41598-024-70616-y.
3
The Association of Telangiectasias with Other Peripheral Vascular Lesions of Systemic Sclerosis.

本文引用的文献

1
The role of nailfold capillaroscopy in the assessment of internal organ involvement in systemic sclerosis: A critical review.甲襞毛细血管显微镜检查在系统性硬化症内脏器官受累评估中的作用:批判性评价。
Autoimmun Rev. 2017 Aug;16(8):787-795. doi: 10.1016/j.autrev.2017.05.019. Epub 2017 May 30.
2
Intact calibers of retinal vessels in patients with systemic sclerosis.系统性硬化症患者视网膜血管管径完整。
J Rheumatol. 2015 Apr;42(4):608-13. doi: 10.3899/jrheum.141425. Epub 2015 Feb 1.
3
Assessment of skin microcirculation by laser Doppler flowmetry in systemic sclerosis patients.
毛细血管扩张与系统性硬化症其他周围血管病变的关联。
Clin Cosmet Investig Dermatol. 2024 Jan 26;17:211-218. doi: 10.2147/CCID.S432422. eCollection 2024.
4
Three-Dimensional Quantitative Magnetic Resonance Imaging Cartilage Evaluation of the Hand Joints of Systemic Sclerosis Patients: A Novel Insight on Hand Osteoarthritis Pathogenesis-Preliminary Report.系统性硬化症患者手部关节的三维定量磁共振成像软骨评估:关于手部骨关节炎发病机制的新见解——初步报告
J Clin Med. 2023 Nov 23;12(23):7247. doi: 10.3390/jcm12237247.
5
Copeptin as a Biomarker of Microcirculation Alterations in Systemic Sclerosis.copeptin作为系统性硬化症微循环改变的生物标志物。
Clin Cosmet Investig Dermatol. 2023 May 25;16:1351-1361. doi: 10.2147/CCID.S409490. eCollection 2023.
6
Role and effectiveness of complex and supervised rehabilitation on overall and hand function in systemic sclerosis patients-one-year follow-up study.复杂性和监督康复对系统性硬化症患者整体和手部功能的作用:一项为期一年的随访研究。
Sci Rep. 2021 Jul 26;11(1):15174. doi: 10.1038/s41598-021-94549-y.
7
Association of Circulating Vascular Endothelial Growth Factor Levels With Autoimmune Diseases: A Systematic Review and Meta-Analysis.循环血管内皮生长因子水平与自身免疫性疾病的关联:系统评价和荟萃分析。
Front Immunol. 2021 May 27;12:674343. doi: 10.3389/fimmu.2021.674343. eCollection 2021.
8
Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis-Case Series Report.基质金属蛋白酶 MMP-2 和 MMP-9、它们的抑制剂 TIMP-1 和 TIMP-2、血管内皮生长因子和 sVEGFR-2 作为系统性硬化症患者缺血性视网膜病变的预测标志物:病例系列报告。
Int J Mol Sci. 2020 Nov 18;21(22):8703. doi: 10.3390/ijms21228703.
通过激光多普勒血流仪评估系统性硬化症患者的皮肤微循环。
Postepy Dermatol Alergol. 2014 Feb;31(1):6-11. doi: 10.5114/pdia.2014.40653. Epub 2014 Feb 25.
4
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.2013年系统性硬化症分类标准:美国风湿病学会/欧洲抗风湿病联盟合作倡议
Arthritis Rheum. 2013 Nov;65(11):2737-47. doi: 10.1002/art.38098. Epub 2013 Oct 3.
5
Chemokines in tissue fibrosis.组织纤维化中的趋化因子。
Biochim Biophys Acta. 2013 Jul;1832(7):1041-8. doi: 10.1016/j.bbadis.2012.11.004. Epub 2012 Nov 15.
6
Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis.系统性硬皮病患者血清可溶性血管内皮生长因子受体-2 水平。
Br J Dermatol. 2010 Apr;162(4):751-8. doi: 10.1111/j.1365-2133.2009.09567.x. Epub 2009 Nov 3.
7
Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy.血管内皮生长因子和血管内皮生长因子受体抑制剂作为癌症治疗中的抗血管生成药物。
Recent Pat Anticancer Drug Discov. 2007 Jan;2(1):59-71. doi: 10.2174/157489207779561426.
8
The immunohistochemical analysis of vascular endothelial growth factors A and C and microvessel density in gingival tissues of systemic sclerosis patients: their possible effects on gingival inflammation.系统性硬化症患者牙龈组织中血管内皮生长因子A和C及微血管密度的免疫组织化学分析:它们对牙龈炎症的可能影响。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Apr;105(4):481-5. doi: 10.1016/j.tripleo.2007.07.021. Epub 2008 Feb 21.
9
A proposal of criteria for the classification of systemic sclerosis.系统性硬化症分类标准的一项提议。
Med Sci Monit. 2004 Nov;10(11):CR615-21. Epub 2004 Oct 26.
10
Elevated vascular endothelial growth factor in systemic sclerosis.系统性硬化症中血管内皮生长因子升高。
J Rheumatol. 2003 Jul;30(7):1529-33.